$BMRA News

Biomerica Commences ~$2.23M Private Placement Of 1.394M Shares At $1.60 Per Share

Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

Biomerica's Ethos Laboratories' Test Now Eligible For Medicare Coverage On Individual Basis Announced By Medicare Administrative Contractor

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

Biomerica Q3 EPS $(0.44) Up From $(0.48) YoY, Sales $987.000K Down From $1.119M YoY

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test

Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria

Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria

Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution

Biomerica EZ Detect System Approved For Nationwide Distribution In Vietnam For At-Home Colorectal Screening

Biomerica Q2 EPS $(0.45) Up From $(0.48) YoY, Sales $1.210M Down From $1.636M YoY

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Biomerica shares are trading higher after the company announced a CMS Medicare payment rate of $300 for its inFoods IBS test.

Biomerica Says CMS Issues Final Pricing Determination For inFoods IBS Test, Establishing National Medicare Payment Rate Of $300 Under CLFS

Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Biomerica Highlights Clinical Trial Showing inFoods IBS Test Significantly Reduces Symptoms Through Guided Dietary Therapy In The Fall 2025 Issue Of Biotherapeutics Quarterly, A Henry Schein Publication